The Tikosyn Prescription Assistance Program is a manufacturer-sponsored initiative that provides Tikosyn at little or no medication cost to qualifying patients based on income and insurance status. The program is designed for AF/AFL patients who are uninsured or underinsured.
Navigating the program on your own means dealing with eligibility verification, cardiology coordination, prior-authorization documentation (Tikosyn REMS / prescriber certification required), and renewal deadlines.
AffordMyPrescriptions eliminates that burden. For a flat $69.95 per month, our Patient Advocates handle every step of your enrollment, from initial application through ongoing refill coordination and renewal.
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$480 | Save ~$410/mo |
| CVS Pharmacy (brand) | ~$500 | Save ~$430/mo |
| Walmart (brand) | ~$370 | Save ~$300/mo |
| Costco (brand) | ~$360 | Save ~$290/mo |
Generic dofetilide | ~$60 | Already low |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
1 Medications
2 Medications
3 Medications
4+ Medications
The Patient Assistance Program is free to apply for and provides Tikosyn at no medication cost if approved. Our $69.95/month service covers full advocacy. With generic dofetilide widely available at low cost, generic is usually the cheaper path for most patients.
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Tikosyn:
Still $350–$500 per month even with the best discount
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Tikosyn assistance.
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Tikosyn (dofetilide) is a Class III antiarrhythmic used for rhythm control in atrial fibrillation/flutter. It selectively blocks the rapidly activating delayed rectifier potassium current (IKr) — prolonging the cardiac action potential and refractory period. Initiation requires inpatient telemetry monitoring for 3 days due to the risk of QT prolongation and torsades de pointes.
How Tikosyn Works:
Atrial fibrillation (AF) causes chaotic electrical activity in the heart, which a rhythm control strategy aims to restore to normal. Dofetilide works by selectively blocking specific potassium channels, which prolongs the cardiac action potential and reduces the heart’s ability to maintain AF. However, this therapeutic mechanism also causes QT prolongation, which carries a risk of triggering a dangerous ventricular tachycardia called torsades de pointes. Because dofetilide is cleared by the kidneys, a patient’s renal function directly determines their safe starting dose.
Form and use:
Initiating the brand Tikosyn requires a mandatory three-day inpatient hospital stay with continuous telemetry monitoring. Doctors measure baseline creatinine clearance and QTc intervals to choose a starting dose, which ranges from 125 mcg to 500 mcg twice daily, though it is not indicated for severe kidney impairment. Doses are carefully adjusted two to three hours after administration based on the patient’s QTc response. Patients can only transition to outpatient care after this safe in-hospital titration, and prescribing doctors must be certified in the Tikosyn REMS program.
Generic availability:
Generic dofetilide is widely available in the United States and offers a substantially cheaper alternative to brand-name Tikosyn. While cardiologists are highly comfortable prescribing the generic, alternative rhythm-control drugs like amiodarone, sotalol, flecainide, propafenone, and brand-only Multaq also exist. Some of these alternatives carry significant toxicities to organs like the lungs and liver, while others require similar inpatient monitoring or are limited to patients without structural heart disease.
Warnings:
Tikosyn carries a Boxed Warning requiring a minimum three-day initiation in a facility equipped for continuous ECG monitoring and cardiac resuscitation. The risk of torsades de pointes is highest during this initial period and is heavily tied to the patient’s dose, renal function, and QTc interval. Additionally, many contraindicated medications can dangerously increase dofetilide levels, requiring a meticulous review of all drug interactions. Electrolyte imbalances like low potassium or magnesium must be corrected to prevent worsening QT prolongation, and renal function must be rechecked periodically.
Brand Tikosyn costs approximately $350–$500 per 30-day supply. Generic dofetilide is dramatically cheaper, often $40–$100/month with a coupon. Through AffordMyPrescriptions, qualifying patients receive Tikosyn at no medication cost — our $69.95 monthly fee covers full advocacy and program management. Most patients find generic dofetilide is the cheaper path.
Tikosyn carries the highest risk of torsades de pointes at initiation — driven by QT prolongation. The 3-day inpatient stay allows: baseline QT/creatinine assessment, observation of QT response 2–3 hours after each of the first few doses (when dose-related QT change is detected), dose adjustment based on early response, and continuous telemetry to detect any arrhythmias that occur. After safe in-hospital initiation, the long-term torsades risk is much lower (though still present).
Yes — many. Several drugs are CONTRAINDICATED with Tikosyn because they substantially raise dofetilide levels: cimetidine, hydrochlorothiazide, verapamil, ketoconazole, itraconazole, prochlorperazine, megestrol, trimethoprim, dolutegravir. Other drugs that prolong QT should be avoided where possible: many antibiotics (azithromycin, clarithromycin, fluoroquinolones), antifungals, antidepressants, antipsychotics, some antiemetics. Tell every prescriber and pharmacist that you take dofetilide.
Dofetilide is renally cleared — kidney impairment dramatically prolongs its half-life and raises levels, increasing QT prolongation and torsades risk. Creatinine clearance determines the starting dose. CrCl <20 is a contraindication. Periodic re-measurement (every 3 months at minimum) catches declining kidney function — dose adjustment or discontinuation may be needed if CrCl worsens.
Amiodarone is the most effective AF rhythm-control drug but has significant long-term toxicities (thyroid, lung, liver, eye, skin). Sotalol is a β-blocker + Class III antiarrhythmic (also requires inpatient initiation for QT monitoring). Tikosyn (dofetilide) is selective Class III — no β-blocker effects; effective in atrial arrhythmias including in patients with structural heart disease. Choice depends on prior treatments, comorbidities, structural heart disease, and renal function.
Many patients with symptomatic AF benefit from catheter ablation (pulmonary vein isolation), which can be more effective than antiarrhythmic drugs for long-term sinus rhythm maintenance. AF ablation may be considered as first-line or second-line rhythm control. Discuss with your cardiologist whether ablation is an option for you alongside or instead of antiarrhythmic drugs.
If denied, we explore alternatives — switching to generic dofetilide (much cheaper), or to a different rhythm-control antiarrhythmic (generic amiodarone, generic sotalol, generic flecainide, generic propafenone), the manufacturer’s copay program for commercially insured patients, or independent foundations such as the American Heart Association, Heart Rhythm Society patient resources, PAN Foundation, or HealthWell Foundation. If we cannot find a path, you won’t be charged our service fee.
If you are struggling with the high cost of Tikosyn, our team may be able to help you access assistance programs — or guide you to generic dofetilide. Check your eligibility today.
Start free by filling out a simple online form.
Our specialist will contact you for a quick welcome call.
Our team handles everything, so you can focus on your health.